What's the Problem With Xeljanz?
The U.S. Food and Drug Administration (FDA) has issued an updated warning about Xeljanz (tofacitinib) indicating that final results from a safety study show that the drugs may increase the risk for thromboembolic events, cardiovascular events, and death, even when taken at the lower dose of 5 mg twice daily.
Previously, Xeljanz had been linked to an increased risk of a venous thromboembolic event (VTE) or well known as a blood clot formation in the veins when used in rheumatoid arthritis patients at a higher dose of 10 mg twice daily. New information shows that the risk is increased at all dose levels including 5mg twice daily.
This may include episodes such as deep vein thrombosis (DVT) in the legs which may result in pulmonary embolism (PE), cerebrovascular accident (CVA), and myocardial infarction (MI), any of which may be serious or life-threatening. Other serious adverse events linked to Xeljanz include opportunistic infections, cancer, and sudden cardiac death.
People or loved ones of those who took Xeljanz and were injured or died after using the medication may be filing Xeljanz class action lawsuits seeking compensation from the drug manufacturer.
Related Article: Xeljanz Lawsuit Update
- Blood clots in the lungs
- Pulmonary embolism (PE)
- Deep vein thrombosis (DVT)
- Non-melanoma skin cancer
- Lung cancer
- Other cancers
- Heart attack
- Cardiovascular risk factor
- Major adverse cardiovascular event
- Ulcerative colitis
- Serious infections
- Immune system problems
- Extrapulmonary tuberculosis
- Invasive fungal infections
- Jaundice (yellowing of the eyes and/or skin)
- Breath chest pain
- Sudden shortness of breath
- Skin rash
- Other Xeljanz side effects explained
Can I File a Class Action?
Only a qualified Xeljanz attorney can determine whether you are eligible to file a lawsuit against Pfizer, the maker of Xeljanz, which is why we are currently offering free case evaluations. Simply fill out the confidential evaluation form below to contact our law firm now.
PLEASE NOTE: Our attorneys have decided against the filing of a class action lawsuit in this litigation, and instead are filing individual lawsuits on behalf of injured parties and/or their family members. We strongly believe that individual suits, and not a class action, are far more beneficial to our clients in terms of overall payout, lawyer fees, and control over their own cases. Contact us today to learn more about your legal rights.
See the other dangerous drug lawsuits our attorneys covered so far.
Get a Free Xeljanz Class Action Lawsuit Evaluation With Our Attorneys
The Pharmaceutical Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial attorneys that focus on the representation of plaintiffs in Xeljanz Class Action Lawsuits. We are handling individual litigation nationwide and currently accepting new blood clot injury and death cases in all 50 states.
Free Xeljanz Class Action Lawsuit Evaluation: Again, if you were harmed after taking Xeljanz to treat rheumatoid arthritis, you should contact our attorneys immediately. Xeljanz patients may be entitled to a settlement for medical expenses by filing a lawsuit and our attorneys can help.